Edgar Filing: ARTHROCARE CORP

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â PROTHRO BRUCE

2. Date of Event Requiring Statement (Month/Day/Year)
05/11/2011

3. Issuer Name and Ticker or Trading Symbol
ARTHROCARE CORP [ARTC]

(Last)

(First)

(Middle)

7500 RIALTO BLVD BLDG TWO, STE 100

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Chief Regulatory Officer & SVP

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

AUSTIN,Â TXÂ 78735

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	20,370 ⁽¹⁾ ⁽²⁾ ⁽³⁾ ⁽⁴⁾	D	Â
Common Stock	728.01 ⁽⁵⁾	I	By managed account

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Option (right to buy)	Â ⁽⁶⁾	03/10/2014	Common Stock	2,055	$ 24.38	D	Â
Non-Qualified Stock Option (right to buy)	Â ⁽⁶⁾	03/10/2014	Common Stock	134	$ 24.38	D	Â
Incentive Stock Option (right to buy)	Â ⁽⁶⁾	02/15/2012	Common Stock	2,969	$ 31.5	D	Â
Non-Qualified Stock Option (right to buy)	Â ⁽⁶⁾	02/15/2012	Common Stock	1,719	$ 31.5	D	Â
Incentive Stock Option (right to buy)	Â ⁽⁶⁾	02/21/2013	Common Stock	584	$ 46.84	D	Â
Non-Qualified Stock Option (right to buy)	Â ⁽⁶⁾	02/21/2013	Common Stock	667	$ 46.84	D	Â
Stock Appreciation Rights	Â ⁽⁶⁾	02/21/2013	Common Stock	6,563	$ 46.84	D	Â
Incentive Stock Option (right to buy)	Â ⁽⁶⁾	02/27/2014	Common Stock	2,771	$ 36.08	D	Â
Stock Appreciation Rights	Â ⁽⁶⁾	02/27/2014	Common Stock	14,550	$ 36.08	D	Â
Incentive Stock Option (right to buy)	Â ⁽⁷⁾	12/16/2016	Common Stock	12,597	$ 23.5	D	Â
Non-Qualified Stock Option (right to buy)	Â ⁽⁷⁾	12/16/2016	Common Stock	27,403	$ 23.5	D	Â
Incentive Stock Option (right to buy)	Â ⁽⁸⁾	02/17/2018	Common Stock	3,526	$ 33.39	D	Â
Non-Qualified Stock Option (right to buy)	Â ⁽⁸⁾	02/17/2018	Common Stock	9,228	$ 33.39	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
PROTHRO BRUCE 7500 RIALTO BLVD BLDG TWO, STE 100 AUSTIN,Â TXÂ 78735	Â	Â	Â Chief Regulatory Officer & SVP	Â

Signatures

Bruce Prothro		05/23/2011
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 1,241 restricted stock units ("RSUs"), from an original grant of 6,206 RSUs, that are scheduled to vest in five (5) successive and equal annual installments measured from February 27, 2007, such that 100% of the RSUs will be fully vested on February 27, 2012. Upon vesting thereof, the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU.
(2)	Includes 2,758 restricted stock units ("RSUs"), from an original grant of 6,895, that are scheduled to vest in five (5) successive and equal annual installments measured from March 5, 2008, such that 100% of the RSUs will be fully vested on March 5, 2013. Upon vesting thereof, the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU.
(3)	Includes 10,000 restricted stock units ("RSUs") that are scheduled to vest in two equal installments on January 1, 2013 and July 1, 2015, such that 100% of the RSUs will be fully vested on July 1, 2015. Upon vesting thereof, the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU.
(4)	Includes 4,204 restricted stock units ("RSUs") that are scheduled to vest in five (5) successive and equal annual installments measured from February 17, 2011, such that 100% of the RSUs will be fully vested on February 17, 2016. Upon vesting thereof, the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU.
(5)	Shares are held in Fidelity account and represent the Company 401(k) match.
(6)	This option is fully vested and exercisable.
(7)	The option vests in 48 equal monthly installments measured from December 16, 2009, such that 100% of the shares subject to the option will be fully vested and exercisable on December 16, 2013.
(8)	The option vests in 48 equal monthly installments measured from February 17, 2011, such that 100% of the shares subject to the option will be fully vested and exercisable on February 17, 2015.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.